Differentiation through R&D and Intellectual Property
First written in FY2016. 18 of 36 entries say "Restated". Latest entry: 2026-10-01.
9 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「As of the end of the fiscal year, patent registrations totaled 606, comprising 428 in Japan and 178 overseas. During the fiscal year, the Company actively filed patent applications for core technologies underlying its services, mainly in smart agriculture and generative AI-related services. Some of these applications have already proceeded to registration, and the Company steadily continued building the intellectual property base underpinning its business competitiveness.」
Patent registrations reached 606, and the Company indicated its policy of continuing to secure rights for peripheral technologies, including functional enhancements, operating UIs and operating methods, in addition to core technologies in smart agriculture and generative AI. - 2026-05-22AdvancedInvestor presentation
「More than 606 patents accumulated」
特許ポートフォリオの累計件数を606件超として示している。 - FY2026-H1AdvancedAnnual report
「The Group's total research and development expenses for the interim consolidated accounting period were ¥411.359 million. The Company will continue to execute its budget for the use of AI technology as a strategic investment activity.」
The Company recorded total research and development expenses of ¥411.359 million and indicated its policy of continuing budget execution for the use of AI technology as a strategic investment. - FY2025AdvancedAnnual report
「Specifically, the core component of the pinpoint time-based spraying service launched in 2022 has been registered as Patent No. 7132680. The Company is also strengthening application patents in priority fields including agriculture, healthcare and construction. In construction, the operating UI that is a feature of OPTiM Geo Scan has been registered as Patent No. 7557919. Foreign patent applications, including international patent applications, totaled 565, and foreign patent registrations totaled 177 as of 28 March 2025.」
The Company patented the core technologies and operating UI of PTS and OPTiM Geo Scan, and disclosed 565 foreign patent applications and 177 foreign patent registrations. It is also pursuing patent applications and registrations for generative AI services. - FY2025-H1RestatedAnnual report
「The Group's total research and development expenses for the interim consolidated accounting period were ¥271.703 million. However, research and development expenses included in selling, general and administrative expenses were ¥269.315 million. This resulted from treating contract revenue related to research and development as a deduction from selling, general and administrative expenses. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」
The Company continued its research and development activities and disclosed total research and development expenses of ¥271.703 million for the interim consolidated accounting period. It stated that there were no material changes in the status of its research and development activities. - FY2024Decline in and continuation of research and development expenses, with explicit use of intellectual propertyAnnual report
「Total research and development expenses incurred by the Group during the consolidated fiscal year were ¥697.502 million. Examples include Patent No. 6290459, Contract Management System, Contract Management Method, and Contract Management Program, which formalized the research and development results of OPTiM Contract, and Patent No. 6928217, Measurement Processing Apparatus, Method and Program, which formalized the research and development results of OPTiM Geo Scan.」
Research and development activities continued, while research and development expenses declined from ¥955.893 million in the previous fiscal year to ¥697.502 million. The Company is linking the research and development results of Contract and Geo Scan to business expansion through patents. - FY2024-Q3Decline in and continuation of research and development expensesAnnual report
「The Group's total research and development expenses for the cumulative third quarter were ¥518.625 million. However, research and development expenses included in selling, general and administrative expenses were ¥495.668 million. This resulted from treating contract revenue related to research and development as a deduction from selling, general and administrative expenses. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
Research and development activities continued, but cumulative third-quarter total research and development expenses declined to ¥518.625 million from ¥750.613 million in the same period of the previous year. - FY2024-Q2Decline in and continuation of research and development expensesAnnual report
「The Group's total research and development expenses for the cumulative second quarter were ¥337.845 million. However, research and development expenses included in selling, general and administrative expenses were ¥327.938 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
Research and development activities continued, but total research and development expenses declined from ¥504.469 million in the same period of the previous year to ¥337.845 million. - FY2024-Q1RestatedAnnual report
「The Group's total research and development expenses for the cumulative first quarter were ¥175.610 million. However, research and development expenses included in selling, general and administrative expenses were ¥174.943 million. This resulted from treating contract revenue related to research and development as a deduction from selling, general and administrative expenses. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The Company stated that there were no material changes in the status of its research and development activities and disclosed total research and development expenses of ¥175.610 million for the cumulative first quarter. - FY2023Decline in and continuation of research and development expensesAnnual report
「Total research and development expenses incurred by the Group during the consolidated fiscal year were ¥955.893 million. However, research and development expenses included in selling, general and administrative expenses were ¥876.968 million.」
Research and development activities continued, while total research and development expenses declined from ¥1,238.951 million in the previous fiscal year to ¥955.893 million. - FY2023-Q3RestatedAnnual report
「The Group's total research and development expenses for the cumulative third quarter were ¥750.613 million. However, research and development expenses included in selling, general and administrative expenses were ¥683.220 million. This resulted from treating contract revenue related to research and development as a deduction from selling, general and administrative expenses. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The Company disclosed research and development expenses of ¥750.613 million for the cumulative third quarter and stated that there were no material changes in the status of its research and development activities. - FY2023-Q2RestatedAnnual report
「The Group's total research and development expenses for the cumulative second quarter were ¥504.469 million. However, research and development expenses included in selling, general and administrative expenses were ¥464.553 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The Company disclosed research and development expenses of ¥504.469 million for the cumulative second quarter and stated that there were no material changes in the status of its research and development activities. - FY2023-Q1RestatedAnnual report
「The Group's total research and development expenses for the cumulative first quarter were ¥245.200 million. However, research and development expenses included in selling, general and administrative expenses were ¥233.158 million. This resulted from treating contract revenue related to research and development as a deduction from selling, general and administrative expenses. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The Company disclosed research and development expenses of ¥245.200 million for the first quarter and stated that there were no material changes in the status of its research and development activities. - FY2022AdvancedAnnual report
「Total research and development expenses incurred by the Group during the consolidated fiscal year were ¥1,238.951 million.」
The Company continued research and development investment and disclosed annual research and development expenses of ¥1,238.951 million. A patent for its contract management system received the Minister of Education, Culture, Sports, Science and Technology Award at the FY2021 Kyushu Regional Invention Awards, and WIPO published a case study on the use of its intellectual property. - FY2022-Q3RestatedAnnual report
「The Group's total research and development expenses for the cumulative third quarter were ¥934.684 million. However, research and development expenses included in selling, general and administrative expenses were ¥862.642 million. This resulted from treating contract revenue related to research and development as a deduction from selling, general and administrative expenses. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The Company disclosed research and development expenses for the cumulative third quarter and stated that there were no material changes in the status of its research and development activities. - FY2022-Q2RestatedAnnual report
「The Group's total research and development expenses for the cumulative second quarter were ¥595.486 million. However, research and development expenses included in selling, general and administrative expenses were ¥543.757 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The Company stated that there were no material changes in its research and development activities and disclosed total research and development expenses of ¥595.486 million for the cumulative second quarter. - FY2022-Q1RestatedAnnual report
「The Group's total research and development expenses for the cumulative first quarter were ¥276.026 million. However, research and development expenses included in selling, general and administrative expenses were ¥251.857 million.」
The Company continued research and development investment and disclosed total research and development expenses of ¥276.026 million for the cumulative first quarter. It also stated that there were no material changes in the status of its research and development activities. - FY2021AdvancedAnnual report
「Total research and development expenses incurred by the Group during the consolidated fiscal year were ¥1,233.405 million. The Land-Use Classification System (Patent No. 6495561), a result of these initiatives, received the Invention Encouragement Award at the FY2020 Kyushu Regional Invention Awards.」
The Company disclosed its annual research and development expenses, and the Land-Use Classification System received the Invention Encouragement Award at the FY2020 Kyushu Regional Invention Awards as a result of its intellectual property strategy. - FY2021-Q3RestatedAnnual report
「The Group's research and development activity expenses for the cumulative third quarter were ¥1,020.044 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The Company stated that there were no material changes in the status of its research and development activities and disclosed cumulative third-quarter research and development activity expenses of ¥1,020.044 million. - FY2021-Q2RestatedAnnual report
「The Group's research and development activity expenses for the cumulative second quarter were ¥777.444 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The Company stated that there were no material changes in the status of its research and development activities and disclosed cumulative second-quarter research and development activity expenses of ¥777.444 million. - FY2021-Q1RestatedAnnual report
「The Group's research and development activity expenses for the cumulative first quarter were ¥445.415 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The Company continued research and development investment in the AI, IoT and robotics fields, disclosing cumulative first-quarter research and development activity expenses of ¥445.415 million. It stated that there were no material changes in the status of its research and development activities. - FY2020AdvancedAnnual report
「The Group's research and development activities are focused mainly on developing new services and enhancing the functions of existing services. Total research and development expenses incurred by the Group during the consolidated fiscal year were ¥1,966.127 million.」
The Company continued research and development for new and existing services and disclosed total research and development expenses of ¥1,966.127 million for the fiscal year ended March 2020. Its intellectual property strategy also included the listing of its cases in a Japan Patent Office casebook and receipt of the Minister of Education, Culture, Sports, Science and Technology Award for its pinpoint pesticide spraying and fertilization technology. - FY2020-Q3AdvancedAnnual report
「Research and development continued to progress smoothly during the third quarter, resulting in the announcement of six AI services: OPTiM AI Camera Mobile, OPTiM AI Camera Lite, OPTiM AI Creator, OPTiM AI Research, OPTiM AI Signage and OPTiM AI Voice Recorder.」
The Company announced six AI services as the results of research and development in the AI, IoT and robotics fields. Cumulative third-quarter research and development activity expenses were ¥1,435.148 million. - FY2020-Q2RestatedAnnual report
「The Group's research and development activity expenses for the cumulative second quarter were ¥961.640 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The Company continued research and development investment in the AI, IoT and robotics fields, disclosing cumulative second-quarter research and development activity expenses of ¥961.640 million. It stated that there were no material changes in the status of its research and development activities. - FY2019AdvancedAnnual report
「As of the end of March 2019, cumulative applications totaled 735, comprising 219 PCT applications, 298 domestic applications and 218 overseas applications, while cumulative registrations totaled 365, comprising 273 domestic registrations and 92 overseas registrations. During the fiscal year ended March 2019, intellectual property generated through research and development comprised 52 applications, including 26 PCT applications and 26 overseas applications, and 67 registrations, including 56 domestic registrations and 11 overseas registrations. In recognition of the intellectual property strategy's contribution to business development in the AI, IoT and robotics fields, the Company received the Intellectual Property Achievement Award from the Japan Patent Office of the Ministry of Economy, Trade and Industry for the fiscal year ended March 2019.」
Cumulative patent applications and registrations totaled 735 and 365, respectively, while applications and registrations during the fiscal year totaled 52 and 67. The Company also received the Intellectual Property Achievement Award. Total research and development expenses were ¥2,180.428 million. - FY2019-Q3RestatedAnnual report
「Against this market backdrop, we are making further active business expansion and research and development investments in the AI, IoT and robotics fields in order to become, as in the previous fiscal year, a company that plays a central role in the Fourth Industrial Revolution. Research and development continued to progress smoothly as planned during the third quarter.」
The Company said it was continuing active business expansion and research and development investment in the AI, IoT and robotics fields and progressing as planned in the third quarter. Research and development activity expenses were ¥1,775.543 million. - FY2019-Q2RestatedAnnual report
「Against this market backdrop, we are making further active business expansion and research and development investments in the AI, IoT and robotics fields in order to become, as in the previous fiscal year, a company that plays a central role in the Fourth Industrial Revolution. Research and development continued to progress smoothly as planned during the second quarter.」
The Company said it was continuing active research and development investment in the AI, IoT and robotics fields and progressing as planned in the second quarter. Research and development activity expenses were ¥1,256.829 million. - FY2019-Q1RestatedAnnual report
「Research and development continued to progress smoothly as planned during the first quarter. In the AI, IoT and robotics fields, we are concentrating development investment on expanding the functions of the platform service OPTiM Cloud IoT OS and various services, and equipping them with functions that meet the needs of each industry. Research and development activity expenses for the cumulative first quarter were ¥583.402 million.」
The Company said it was proceeding as planned with development investment and functional enhancements in the AI, IoT and robotics fields, and disclosed first-quarter research and development activity expenses of ¥583.402 million. - FY2018AdvancedAnnual report
「As of the end of March 2018, cumulative applications totaled 683, comprising 193 PCT applications, 298 domestic applications and 192 overseas applications, while cumulative registrations totaled 298, comprising 217 domestic registrations and 81 overseas registrations. During the fiscal year ended March 2018, intellectual property generated through research and development comprised 85 applications, including 52 PCT applications, 2 domestic applications and 31 overseas applications, and 101 registrations, including 75 domestic registrations and 26 overseas registrations. The annual number of patent registrations reached a record high both domestically and overseas, making the year a foundation for establishing businesses in the AI, IoT and robotics fields.」
Cumulative applications and registrations totaled 683 and 298, respectively, while the 101 patent registrations during the fiscal year reached record highs both domestically and overseas. - FY2018-Q3RestatedAnnual report
「The amount spent on research and development activities across the Company during the cumulative third quarter was ¥1,125.156 million. There were no material changes in the status of the Company's research and development activities during the cumulative third quarter.」
The Company disclosed cumulative third-quarter research and development activity expenses of ¥1,125.156 million and stated that there were no material changes in the status of its research and development activities. - FY2018-Q2RestatedAnnual report
「Against this market backdrop, we regard the current fiscal year as an important year in becoming a company that plays a central role in the Fourth Industrial Revolution, and are pursuing more active business expansion and research and development investment than ever in the AI, IoT and robotics fields. Research and development activity expenses for the cumulative second quarter were ¥642.598 million. There were no material changes in the status of the Company's research and development activities during the cumulative second quarter.」
The Company reiterated its policy of active investment in the AI, IoT and robotics fields, and disclosed cumulative second-quarter research and development activity expenses of ¥642.598 million. It stated that there were no material changes in the status of its research and development activities. - FY2018-Q1RaisedAnnual report
「Against this market backdrop, we regard the current fiscal year as an important year in becoming a company that plays a central role in the Fourth Industrial Revolution, and are pursuing more active business expansion and research and development investment than ever in the AI, IoT and robotics fields. Research and development activity expenses for the cumulative first quarter were ¥294.896 million.」
The Company indicated that it would make more aggressive research and development investments than before in the AI, IoT and robotics fields, and disclosed cumulative first-quarter research and development activity expenses of ¥294.896 million. - FY2017-Q3RestatedAnnual report
「The amount spent on research and development activities across the Company during the cumulative third quarter was ¥914.316 million. There were no material changes in the status of the Company's research and development activities during the cumulative third quarter.」
Research and development activity expenses for the cumulative third quarter were ¥914.316 million, with no material changes in the status of research and development activities. - FY2016First statedAnnual report
「Since its founding, we have regarded research and development activities and the acquisition of the intellectual property they generate as the foundation of our differentiation from other companies, and have focused on both. Going forward, we will continue to conduct active research and development in new fields, build our intellectual property portfolio, and strengthen our personnel and organizational structure for research and development, with the aim of creating new markets and driving innovation simultaneously. We will also place an even greater focus on obtaining patents overseas.」
As of the filing date, the number of applications was 430 and the number of registered patents was 156. In the fiscal year ended March 2016, there were 117 applications and 36 registered patents, making the annual number of patent applications a record high.